Nula Therapeutics is a biotechnology company developing a new class of small molecules targeting the nuclear envelope – a key regulator of gene expression and cellular function implicated in chronic disease and the biology of aging. By developing targeted small molecules that correct cellular dysfunction at the level of nuclear organization, Nula aims to restore health and extend healthspan across a spectrum of age-related conditions, including metabolic dysfunction, metabolic dysfunction-associated steatohepatitis (MASH), neurodegeneration, and cancer. 

Nula Therapeutics

Org chart

Teams

Offices

Nula Therapeutics

Org chart

Teams

Offices

Related companies